Dr. Samuel Matthias Meier-Menches, Privatdoz. BSc MSc



Englinger, B., Laemmerer, A., Moser, P., Kallus, S., Roehrl, C., Pirker, C., Baier, D., Mohr, T., Niederstaetter, L., Meier-Menches, S. M., Gerner, C., Gabler, L., Gojo, J., Timelthaler, G., Senkiv, J., Jaeger, W., Kowol, C. R., Heffeter, P., & Berger, W. (2020). Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib. International Journal of Cancer. https://doi.org/10.1002/ijc.32924


Kreutz, D., Gerner, C., & Meier-Menches, S. M. (2019). Enabling Methods to Elucidate the Effects of Metal-based Anticancer Agents. In A. Vessieres, S. M. Meier-Menches, & A. Casini (Eds.), Metal-based Anticancer Agents (pp. 246-270). Royal Society of Chemistry. RSC Metallobiology, No. 14, Vol.. 2019-January https://doi.org/10.1039/9781788016452-00246

Casini, A., Vessières, A., & Meier-Menches, S. M. (2019). Metal-based Anticancer Agents. Royal Society of Chemistry. Metallobiology

van Dijk, F., Teekamp, N., Post, E., Schuppan, D., Kim, Y. O., Zuidema, J., Steendam, R., Klose, M. H. M., Meier-Menches, S. M., Casini, A., Horvatovich, P. L., Sijbrandi, N. J., Frijlink, H. W., Hinrichs, W. L. J., Poelstra, K., Beljaars, L., & Olinga, P. (2019). The antifibrotic potential of a sustained release formulation of a PDGF beta-receptor targeted rho kinase inhibitor. Journal of Controlled Release, 296, 250-257. https://doi.org/10.1016/j.jconrel.2018.12.039


Klose, M. H. M., Theiner, S., Varbanov, H. P., Hoefer, D., Pichler, V., Galanski, M., Meier-Menches, S. M., & Keppler, B. K. (2019). Development and Validation of Liquid Chromatography-Based Methods to Assess the Lipophilicity of Cytotoxic Platinum(IV) Complexes. In M. Contel (Ed.), Unconventional Anticancer Metallodrugs and Strategies to Improve their Pharmacological Profile Multi-disciplinary digital publishing institute (MDPI). Inorganics https://doi.org/10.3390/books978-3-03921-316-0




Neuditschko, B., Janker, L., Niederstätter, L., Brunmair, J., Meier-Menches, S. M., & Gerner, C. (2018). Response profiling shows synergistic effects of the clinically successful combination therapy all-trans retinoic acid and arsenic trioxide. Poster session presented at The Austrian Proteomics and Metabolomics Research Symposium APMRS 2018, Wien, Austria.


Muqaku, B., Eisinger, M., Meier-Menches, S. M., Tahir, A., Pukrop, T., Haferkamp, S., Slany, A., Reichle, A., & Gerner, C. (2018). Reprogramming of organ functions via systemic calcium mobilization. In Book of Abstracts





Mass Spectrometry for Elucidating Activation Mechanisms and Modes of Action of Anticancer Metallodrugs on the Molecular Level

Samuel Matthias Meier-Menches (Invited speaker)
10 Jul 2020

Activity: Talks and presentationsTalk or oral contributionScience to Science


Mass Spectrometric Techniques to Study Reactive Metallodrugs on the Molecular Level

Samuel Matthias Meier-Menches (Invited speaker)
5 Mar 2020

Activity: Talks and presentationsTalk or oral contributionScience to Science


Elucidating Activation Mechanisms and Cellular Effects of Anticancer Metallodrugs on the Molecular Level

Samuel Matthias Meier-Menches (Invited speaker)
28 Nov 2019

Activity: Talks and presentationsTalk or oral contributionScience to Science


Affinity-Mass Spectrometry to Determine Target Proteins of Reactive Small Molecules

Samuel Matthias Meier-Menches (Speaker)
30 Sep 2019

Activity: Talks and presentationsTalk or oral contributionScience to Science


Affinity-Mass Spectrometry to Determine Target Proteins of Reactive Small Molecules

Samuel Matthias Meier-Menches (Speaker)
10 Mar 2019

Activity: Talks and presentationsTalk or oral contributionScience to Science


Eicosanoids as underestimated molecular players relevant for tumor biology and mechanisms of metastasis

Lukas Janker (Invited speaker), Laura Niederstätter (Contributor), Benjamin Neuditschko (Contributor), Julia Brunmair (Contributor), Samuel Matthias Meier-Menches (Contributor), Christopher Gerner (Contributor)
6 Dec 2018

Activity: Talks and presentationsTalk or oral contributionScience to Science


Emerging Proteomics Methods to Elucidate Metallodrug Effects in the Cellular Context

Samuel Matthias Meier-Menches (Invited speaker)
24 Jun 2018

Activity: Talks and presentationsTalk or oral contributionScience to Science


Targeting G-Quadruplex Nucleic Acid Structures with Caffeine Gold Compounds for Cancer Treatment

Samuel Matthias Meier-Menches (Invited speaker)
29 Nov 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


Elucidating the Target Selectivity of Metal-based Anticancer Agents

Samuel Matthias Meier-Menches (Invited speaker)
25 Oct 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


Aging-related proteome alterations in B cells may predispose for chronic lymphocytic leukemia

Rupert Laurenz Mayer (Speaker), Astrid Slany (Contributor), Andrea Bileck (Contributor), Johanna Mader (Contributor), Samuel Matthias Meier (Contributor), Tobias Pukrop (Contributor), Albrecht Reichle (Contributor), Josef D. Schwarzmeier (Contributor), Christopher Gerner (Contributor)
6 Sep 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma

Besnik Muqaku (Speaker), Martin Eisinger (Contributor), Samuel Matthias Meier (Contributor), Ammar Tahir (Contributor), Tobias Pukrop (Contributor), Sebastian Haferkamp (Contributor), Astrid Slany (Contributor), Albrecht Reichle (Contributor), Christopher Gerner (Contributor)
6 Sep 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


On the molecular mechanism of action of organometallic anticancer drugs

Christopher Gerner (Speaker), Samuel Matthias Meier (Contributor), Dominique Kreutz (Contributor), Tamara Weiss (Contributor), Andrea Bileck (Contributor), Bernhard Keppler (Contributor), Gerhard Wiche (Contributor)
14 Aug 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


Unravelling the Reactivity of Gold ‐ based Metallodrugs with Zinc Finger Domains and G ‐ Quadruplex DNA by Mass Spectrometry

Samuel Matthias Meier-Menches (Speaker)
14 Aug 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


Post-digestion stabilization of osmium enables quantitation by ICP-MS in cell culture and tissue

Matthias Klose (Speaker), Michaela Hejl (Contributor), Petra Heffeter (Contributor), Michael Jakupec (Contributor), Samuel Matthias Meier (Contributor), Walter Berger (Contributor), Bernhard Keppler (Contributor)
17 May 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


DNA vs. Protein – Capillary Zone Electrophoresis–Mass Spectrometry to characterize Metallodrug binding Preferences

Christian Artner (Speaker), Hannah U. Holtkamp (Contributor), Christian G. Hartinger (Contributor), Samuel Matthias Meier (Contributor), Bernhard Keppler (Contributor)
12 May 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science


Proteomics for Understanding Metallodrug Effects

Samuel Matthias Meier-Menches (Invited speaker), Dominique Kreutz (Contributor), Bernhard Keppler (Contributor), Christopher Gerner (Contributor)
4 Dec 2016

Activity: Talks and presentationsTalk or oral contributionScience to Science


Proteomics for Understanding Metallodrug Effects

Samuel Matthias Meier-Menches (Speaker), Christopher Gerner (Contributor)
5 Sep 2016

Activity: Talks and presentationsTalk or oral contributionScience to Science


Reproducible quantification of metabolites from fingertips via triple-quadrupole mass spectrometry

Samuel Matthias Meier (Speaker)
8 May 2016

Activity: Talks and presentationsTalk or oral contributionOther


Mass spectrometry based assays in preclinical metallodrug research

Samuel Matthias Meier (Invited speaker)
20 Nov 2014

Activity: Talks and presentationsTalk or oral contributionOther


The Structural Determinants for Cytotoxic Activity of a Ruthenium Arene Peptide Conjugate

Samuel Matthias Meier (Speaker)
8 Apr 2013

Activity: Talks and presentationsTalk or oral contributionOther


(Thio)pyronederived organometallics: an approach for new metalbased anticancer drugs

Samuel Matthias Meier (Contributor)
18 Jun 2012

Activity: Talks and presentationsTalk or oral contributionOther



Top-Down High Resolution Mass Spectrometry of Ubiquitin-Oxaliplatin Adducts

Samuel Matthias Meier (Speaker)
23 Feb 2011

Activity: Talks and presentationsTalk or oral contributionOther


Dissecting Temporal Metallodrug Effects in Cancer Cells

Samuel Matthias Meier-Menches (Speaker), Christopher Gerner (Contributor)
30 Jun 2010

Activity: Talks and presentationsTalk or oral contributionScience to Science


Dissecting Temporal Metallodrug Effects in Cancer Cells

Samuel Matthias Meier-Menches (Speaker), Christopher Gerner (Contributor)
30 Jun 2010

Activity: Talks and presentationsTalk or oral contributionScience to Science


Investigation of the Binding Interaction of Oxaliplatin to Ubiquitin by Mass Spectrometric Methods

Samuel Matthias Meier (Speaker)
29 Mar 2010

Activity: Talks and presentationsTalk or oral contributionOther


Affinity-Mass Spectrometry to Determine Target Proteins of Reactive Small Molecules

Samuel Matthias Meier-Menches (Speaker)
10 Mar 2010

Activity: Talks and presentationsTalk or oral contributionScience to Science


Department of Analytical Chemistry

Währinger Straße 38
1090 Wien

samuel.meier@univie.ac.at